Who we are
As a leading global clinical-stage biopharmaceutical company, we strive to create transformative medicines to protect and improve people’s lives. Fueled by our proprietary RNA technology platform combined with two decades of science and manufacturing excellence, we are dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Event Highlight
Annual General Meeting 2021
June 24, 2021 | 02:00 P.M. CEST
Virtual
The Annual General Meeting (the “AGM”) of Shareholders of CureVac N.V. (the “Company”) will be held on Thursday, June 24, 2021, at 2:00 p.m. Central European Summer Time. The AGM will be held entirely virtually, without physical attendance of shareholders or others with meeting rights. You will not be able to vote during the AGM and your proxy to vote must be received no later than 5:59 a.m. Central European Summer Time on Tuesday, June 22, 2021.